Leukemia Stem Cells Are Characterized By CLEC12A Expression and Chemotherapy Refractoriness That Can be Overcome By Targeting with Chimeric Antigen Receptor T Cells

被引：17
|
作者：
Kenderian, Saad S.
Ruella, Marco
Shestova, Olga
Klichinsky, Michael
Kim, Miriam Y.
Soderquist, Craig
Bagg, Adam
Singh, Reshma
Richardson, Celeste
Young, Regina M.
June, Carl H.
Gill, Saar I.
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.766.766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
766
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells
    Wang, Shijie
    Wei, Wenwen
    Yuan, Yuncang
    Sun, Bin
    Yang, Dong
    Liu, Nan
    Zhao, Xudong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [42] Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
    Guo, Yelei
    Feng, Kaichao
    Wang, Yao
    Han, Weidong
    PROTEIN & CELL, 2018, 9 (06) : 516 - 526
  • [43] Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells
    Shijie Wang
    Wenwen Wei
    Yuncang Yuan
    Bin Sun
    Dong Yang
    Nan Liu
    Xudong Zhao
    Journal of Translational Medicine, 21
  • [44] Targeting cancer stem cells by using chimeric antigen receptor-modifled T cells: a potential and curable approach for cancer treatment
    Yelei Guo
    Kaichao Feng
    Yao Wang
    Weidong Han
    Protein & Cell, 2018, 9 (06) : 516 - 526
  • [45] Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells
    Reighard, Seth D.
    Cranert, Stacey A.
    Rangel, Kelly M.
    Ali, Ayad
    Gyurova, Ivayla E.
    de la Cruz-Lynch, Arthur T.
    Tuazon, Jasmine A.
    Khodoun, Marat, V
    Kottyan, Leah C.
    Smith, David F.
    Brunner, Hermine, I
    Waggoner, Stephen N.
    CELL REPORTS MEDICINE, 2020, 1 (01)
  • [46] Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
    Gill, Saar
    Tasian, Sarah K.
    Ruella, Marco
    Shestova, Olga
    Li, Yong
    Porter, David L.
    Carroll, Martin
    Danet-Desnoyers, Gwenn
    Scholler, John
    Grupp, Stephan A.
    June, Carl H.
    Kalos, Michael
    BLOOD, 2014, 123 (15) : 2343 - 2354
  • [47] Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
    Yu, Wei
    Zhang, Hang
    Yuan, Yuncang
    Tang, Jie
    Chen, Xinchuan
    Liu, Ting
    Zhao, Xudong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [48] A TANDEM CHIMERIC ANTIGEN RECEPTOR THAT MEDIATES BISPECIFIC ACTIVATION AND TARGETING OF T-CELLS
    Hegde, Meenakshi
    Grada, Zakaria
    Byrd, Tiara
    Shaffer, Donald R.
    Ghazi, Alexia
    Brawley, Vita S.
    Corder, Amanda
    Schoenfeld, Kurt
    Dotti, Gianpietro
    Heslop, Helen
    Gottschalk, Stephen
    Wels, Winfried
    Baker, Matthew L.
    Ahmed, Nabil
    NEURO-ONCOLOGY, 2012, 14 : 47 - 48
  • [49] Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin
    Mishima, Yuta
    Okada, Shintaro
    Ishikawa, Akihiro
    Wang, Bo
    Waseda, Masazumi
    Kaneko, Mika K.
    Kato, Yukinari
    Kaneko, Shin
    REGENERATIVE THERAPY, 2025, 28 : 292 - 300
  • [50] GD2-specific chimeric antigen receptor T cells targeting retinoblastoma
    Sujjitjoon, Jatuporn
    Atchaneeyasakul, La-ong Sri
    Tsao, Shih-Ting
    Sayour, Elias
    Yenchitsomanus, Pa-thai
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
12345